chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Reports that injection "hurt this time" in comparison to last time. Reported a tingling sensation immediately. He did not tell staff. Approx 20-30 min post vax he reported to staff that he had a tingly feeling radiating to face and arm. No other s/sx reported. PHN confirmed that injection had been placed appropriately in deltoid muscle. Discussed s/sx of allergy. Advised to seek medical treatment if he had worsening or persistent symptoms.
Covid19 breakthrough. 1st vaccine received on 03/19/2021. 58 y/o PMH lung CA, ESRD on HD, AVF, CVA, HTN, HLD presents to ED after positive Covid test the day before. Patient was unable to have dialysis and arrived c/o cough, SOB, and fever. CXR-multifocal PNA, Room air sat 99%. T-103. Patient treated with IV ABX/Steroids.
Information has been received from a physician concerning a 38 month old pt with no pre-existing allergies, birth defects, or medical conditions and a hx of varicella exposure who on 12/11/1997 was vaccinated with a first dose of varicella virus vaccine in the left arm. On 2/20/00, the pt developed "clinical varicella that consisted of 20-30 lesions with no fever." Subsequently the pt recovered.
100 Degree Fever; Headache; This is a spontaneous report from a contactable consumer (patient himself). A 63-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration, administered in Arm Left on 12Mar2021 09:00 (at the age of 63-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history included blood pressure increased, gout, cardiac disorder, hernia and COVID-19 from an unknown date and unknown if ongoing. Patient had not any known allergies. Other medications (concomitant medications) in two weeks was reported as yes (drugs not specified). The patient experienced 100 degree fever and headache on 12Mar2021 23:00. Patient did not receive any treatment for adverse event. The outcome of both the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt was given covid pfizer booster gray top inadvertently diluted with 1.8 ml sodium chloride
Localized nonpainful swelling and redness surrounding area of vaccination. Uncertain if in area of PROQUAD or KINRIX.
shingles; first dose of Shingrix on Feb, 2020 / did not receive the second dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 80-year-old female patient who received Herpes zoster (Shingrix) (batch number 3C37A, expiry date 30th April 2022) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In February 2020, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 5 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows:  The age at vaccination was not applicable for 2nd dose. The patient experienced shingles after 1st dose of shingrix. Till the time of reporting, the patient did not receive the 2nd dose of the vaccine, which led to incomplete course of vaccination. The reporter consented to follow up.
Appendicitis - surgical procedure to remove appendix Swollen Lymph nodes in groin and vaginal cyst.
Anaphylactic reaction: swelling, rash, runny nose, acute bronchospasm
Client passed away on 5/12/2021, she had been residing at assisted living facility.
SIBO - 6 months of bloating, pain, burning sensation and gas before getting diagnosed.  Still dealing with these issues and not resolved. Potential GERD - Slight issues occasionally but now dealing with it constantly. Taking acid medications after GI instruction.
Sore arm with the other couple doses; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm with the other couple doses) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm with the other couple doses). At the time of the report, PAIN IN EXTREMITY (Sore arm with the other couple doses) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2022-538679, MOD-2022-538687, MOD-2022-538684 (Patient Link).
pt recv vax & exp muscle weakness in legs & deltoids. Annual follow-up received on 11/27/00 provides no additional data.
The patient developed palpitations, lightheadedness and nausea and came to the ED and was found to have sinus tachycardia. Unclear if it is a vaccine reaction or due to anxiety or severe iron deficiency anemia.
Arthralgia, joint and bone pain, lower back, waist, neck, knees.
Symptoms were not critical but I began experiencing sensations and pressure in my chest area. It happens most often on the left side of my chest but I have felt it in the middle as well as on the right side of my chest.  I had a lot of instances were I felt like I was out of oxygen. I would breathe deeply and it would pass. There were times when I was sitting and working at my computer and it would feel as if my heart was just out of energy - I'd have to breathe deeply and it would pass in seconds. Because I didn't have anything to compare the first Booster shot to, I went through a plethora of test on my heart to ensure I was alright. Agency did not find anything but they did say that I had a leaky heart valve. Dr. reported that it is somewhat common and it is not a major problem currently. These sensations went on for a while and then tapered off. Sometimes it felt like pressure, other times like a cat walking across my chest, or like little fluttering sensations. It never really hurt bit I knew something was going on.   On May 3, 2022, I took my second vaccine. The sensations started immediately, approximately 30 minutes after leaving Agency. I felt pressure, as if I didn't have the normal amount of oxygen. I'd have to breathe deeply and that would help to clear up the feeling. These sensations do not last for long periods of time but I might feel them, as of today, about two to three times a day. When they first started, I could feel them maybe 5 or 6 times a day. It does seem like the sensation episodes are getting further and further apart.
Immediate severe pain in right shoulder, causing a vasovagal reaction. Continuing pain, of a moderate level, from the moment of vaccination through at least two weeks (the pain resolved gradually, but only now would I say it is fully resolved, four weeks after the injection.) Restriction of movement for some time after the shot due to pain in shoulder/upper deltoid. Visit to primary care doctor resulted in the diagnosis of acute bursitis (never had before) due to the vaccine having been administered into the bursa. A prescription for Prednisone was given 1 week after the initial injury, but by this time the symptoms were beginning to decrease, so I chose to wait and rehabilitate the shoulder through exercise.
left me paralyzed on my right side; Patient had a severe stroke; This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (Patient had a severe stroke) and HEMIPLEGIA (left me paralyzed on my right side) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The patient had no history or stroke or risk previously.     On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jul-2021, the patient experienced CEREBROVASCULAR ACCIDENT (Patient had a severe stroke) (seriousness criterion medically significant). On 24-Jan-2022, the patient experienced HEMIPLEGIA (left me paralyzed on my right side) (seriousness criterion medically significant). At the time of the report, CEREBROVASCULAR ACCIDENT (Patient had a severe stroke) and HEMIPLEGIA (left me paralyzed on my right side) outcome was unknown.            No concomitant medications were reported.  The patient believed that these might have been attributed to the vaccine.  No treatment medications were reported.  Company Comment: This is a Spontaneous case reported by a consumer, concerning a patient of unknown age and gender, with no history of stroke or risk factors, who experienced the unexpected and serious (due to medically significant) events of Cerebrovascular accident (AESI) and Hemiplegia. Cerebrovascular accident occurred approximately 3 months and a half after mRNA-1273 vaccine, administered as second dose within COVID-19 vaccination schedule. Hemiplegia occurred approximately 9 months and a half after the same dose. Patient reported having a severe stroke that left him/her paralyzed on his/her right side. No information disclosed about diagnostic tests performed, clinical course or treatments received. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a Spontaneous case reported by a consumer, concerning a patient of unknown age and gender, with no history of stroke or risk factors, who experienced the unexpected and serious (due to medically significant) events of Cerebrovascular accident (AESI) and Hemiplegia. Cerebrovascular accident occurred approximately 3 months and a half after mRNA-1273 vaccine, administered as second dose within COVID-19 vaccination schedule. Hemiplegia occurred approximately 9 months and a half after the same dose. Patient reported having a severe stroke that left him/her paralyzed on his/her right side. No information disclosed about diagnostic tests performed, clinical course or treatments received. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Unable to sleep at all/way too much energy/beyond wired; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (unable to sleep at all/way too much energy/beyond wired) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Oct-2021, the patient experienced INSOMNIA (unable to sleep at all/way too much energy/beyond wired). At the time of the report, INSOMNIA (unable to sleep at all/way too much energy/beyond wired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided.  Concomitant medication was not provided.
Shortly after vaccination, my daughters behavior spiraled out of control. She began having rage episodes and sensory meltdowns multiple times a day, that lasted up to an hour per episode. She began stimming, wringing her hands, chewing on her fingers, scooting along the floor and needing constant physical stimulation. She was unable to sit still for more than 1-2 minutes at a time. She became extremely inflexible and rigid in personality, unable to handle even the slightest change in schedule. She began mixing up her letters. She was eventually diagnosed with PANDAS and multiple chemical sensitivity one year after her 5 year shots (as documented above), during which time we were actively trying to pinpoint what was wrong with her. It is obvious that it began with this vaccination.
onn5/2/2022 patient mentioned above received extra dose of HIB and Prevnar. CMA received a verbal order to give DTAP HIB HEP A from Provider. CMA understood DTAP HIB And Prevnar.   Provider spoke to the parent that same night as myself spoke to mom.
Positive Covid test; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive Covid test) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Positive Covid test). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive Covid test) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant  information was  provided. No Treatment information was  provided.
bottom eyelid similar to fever blister and bump/blister underneath eye; Swelling in left eye, Swelling was about 3-4 mm in length.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Oct2022 at 14:30 as dose 3 (booster), single (Lot number: GH9702) at the age of 38 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Covid-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes. Concomitant medication(s) included: ZYRTEC [CETIRIZINE HYDROCHLORIDE]. Vaccination history included: BNT162b2 (Dose 1, Single. Batch/Lot No: EW0164), administration date: 16Apr2021, for COVID-19 immunization; BNT162b2 (Dose 2, Single. Batch/Lot No: EW0170), administration date: 07May2021, for COVID-19 immunization. The following information was reported: EYE SWELLING (non-serious) with onset 08Oct2022 at 20:00, outcome "not recovered", described as "Swelling in left eye, Swelling was about 3-4 mm in length."; BLISTER (non-serious) with onset 08Oct2022 at 20:00, outcome "not recovered", described as "bottom eyelid similar to fever blister and bump/blister underneath eye". Therapeutic measures were not taken as a result of blister, eye swelling.  Additional information: The patient had no known allergies. Facility type vaccine was pharmacy or drug store. No other vaccine was received in four weeks. Other medication in two weeks included Zyrtec. The patient was not tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Large rash noted to the abdomen under the breasts. Warm. No bumps, no pain. Not spreading at this time. Pt felt "under the weather" from the flu shot. 10/4/23 woke up with the rash.
Expired vaccine given. Exp 1/28/23, given 1/30/23.  No reaction
pt recv vax 930AM; no contraindication noted;pt returned to clinic approx 3PM-eyes were red, swollen & watery;pt sounded congested AEB sniffling;face & arms had sl red, flushed appearance;c/o throating hurting;hard to swallow; & chest
Unauthorized Age Patient Received the First Dose; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized Age Patient Received the First Dose) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized Age Patient Received the First Dose). On 17-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Unauthorized Age Patient Received the First Dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medicines were not provided.
I am in menopause for 2 years and 10 weeks after I received the 2nd vaccine shot I began bleeding on 8/6/21. I started bleeding as if I was having a period cycle.  I started off spotting and by the 2nd day I was bleeding as if I was having my period. I was also cramping for a few days and releasing small blood clots. I have not bled or spotted since I began menopause.  I bled for 12 days and when I was getting my cycle,  it only lasted 5-6 days.  This bleeding led me to start thinking that I had cancer!!
Nausea 2/21 at 12:45 am, headache 2/21 at 5:00 am, severe hotflash followed by severe weakness and passing out 2/21 at 7:15 am. I was extremely weak and could barely move, unable to get up off the floor for about 20 minutes after passing out. Then weak and and extremely fatigued for the remainder of the day (stayed home from work). Felt fine the following day.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On an unspecified date the patient was vaccinated with 3 doses of RECOMBIVAX HB (lot # not reported). On an unspecified date the patient failed to seroconvert after receiving 3 doses of RECOMBIVAX HB. The outcome of event was reported as not recovered. Additional information has been requested.
Red bump was at injection site for 2 days after dose. On day 8, small red spot was back. It started out about 2 inches wide. Spot was raised and itchy. Over the next few days the spot grew to about 8 inches wide and 4 inches long. The spot was slightly itchy and raised. Arm was sore during this time as well. The spot eventually faded after 5ish days. There is still a faint bruise-like coloring where this occurred.
This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (She has been breastfeeding) in a patient of an unknown age and gender exposed to mRNA-1273 (Moderna COVID-19 Vaccine), while the mother received the product for COVID-19 vaccination. MEDICAL HISTORY (Parent): maternal exposure during breastfeeding. No Medical History information was reported. On 07-Jul-2021, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 07-Aug-2021, the patient was diagnosed with EXPOSURE VIA BREAST MILK (She has been breastfeeding). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 07-Aug-2021, EXPOSURE VIA BREAST MILK (She has been breastfeeding) had resolved. This case was linked to MOD-2021-283789 (Parent-Child Link). See case MOD-2021-283789 for details regarding the Parent case.
Patient  vomiting unspecified. EMS was called vitals BP 118/76 BG 142  100% O2 HR 66.  Patient treated and transported by the EMS to the hospital.
On Friday (8/20/2021) morning, I noticed red blotch marks on my upper clavicle near my neck.  Wasn't burning or anything.  Just there and very splotchy.  Thought I'd keep an eye on it.  On Saturday (8/21/2021) late afternoon, I came back from my ill mother's house after doing some refrig clean out.  As soon as I got home, I felt pain in my lower back immediately.  Kind of pulsing throbbing pain... almost to the point that it could cut right through you.  Thought maybe it was because of the work at my mom's or the office work I do causing back problems.  Decided to rest it as best I can.  On Sunday (8/22/2021), I could barely get out of bed because of the pain in the morning.  I rested most of the day.  It was very difficult to get in and out of bed and walk around.  Hurt very badly.  I did try heat in the shower, an ice pack, and linement.  On Monday (8/23/2021), still having trouble getting out of bed and walking around.  I had to lift my legs up to get into the car which I never have to do.  I had trouble at work and getting into the office building.  I rested when I got home.  Very difficult to get into and out of bed.  Hurt badly.  When I went to try to take a shower and get the warm heat on my back, I found I had more trouble getting out of bed.  Nearly fell on the floor.  I managed to struggle to get to the floor.  I couldn't straighten up.  Then I got dizzy and blacked out.  I fell back onto the bed.  Was out for about an hour.  I struggled to get back up.  I managed to get into the shower and get my teeth brushed, but still was hurting badly.  I notice new pain on the right hip area.  Still hurting today.
On 11/20/02 Mom noticed that his L deltoid was swollen, red and warm to touch.  Redness and swelling continued to increase.  Mom contacted ER on evening of 11/20/02 by telephone (not seen) and was told to ice the area. Attempted to contact Mom for follow-up, left messages but was unable to reach.
This spontaneous report was received from a female nurse of unknown age, reporting on herself. The patient's concurrent conditions, medical history or concomitant medications were not reported. On an unknown date, the patient received PNEUMOVAX 23 (strength, dose, route, site of administration, lot # and expiry date were not reported) and "it hurt". She additionally reported that injection of PNEUMOVAX 23 was painful for most patients. The outcome of adverse event was not reported. The causality assessment between adverse event and PNEUMOVAX 23 was not provided. This is one of several reports from the same source. Additional information has been requested.
she had her period for the first time after getting the vaccine and it was very heavy with large clots; tired; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (she had her period for the first time after getting the vaccine and it was very heavy with large clots) and FATIGUE (tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M26A) for COVID-19 vaccination.     Concurrent medical conditions included Lupus syndrome, Idiopathic thrombocytopenia and Epilepsy. Concomitant products included LAMOTRIGINE and VENLAFAXINE HYDROCHLORIDE (EFFEXOR) for an unknown indication.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (she had her period for the first time after getting the vaccine and it was very heavy with large clots) and FATIGUE (tired). At the time of the report, HEAVY MENSTRUAL BLEEDING (she had her period for the first time after getting the vaccine and it was very heavy with large clots) and FATIGUE (tired) outcome was unknown. Not Provided          No Treatment information provided.